External validation of a model to predict risk of keratinocyte skin cancer after a renal transplantation in a Western European cohort.
External validation of a model to predict risk of keratinocyte skin cancer after a renal transplantation in a Western European cohort.
Br J Dermatol. 2020 Jun 20;:
Authors: Verhage EJ, Nelemans PJ, van Kuijk SMJ, Christiaans MHL, Kelleners-Smeets NWJ
Abstract
Renal transplant recipients (RTRs) face an increased risk of developing keratinocyte skin cancer (KSC) due to their lifelong immunosuppressive drug use. Current recommendations call for 6- to 12-monthly skin examinations for all RTRs. To develop a more personalized screening procedure, Urwin, et al identified the most significant KSC risk factors in an Australian sample and developed a predictive index (PI) that stratifies patients into high-, medium- and low-risk groups. We have externally validated this PI and evaluated its geographic transportability to The Netherlands.
PMID: 32562548 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Verhage EJ, Nelemans PJ, van Kuijk SMJ, Christiaans MHL, Kelleners-Smeets NWJ Tags: Br J Dermatol Source Type: research
More News: Australia Health | Cancer | Cancer & Oncology | Dermatology | Netherlands Health | Skin | Skin Cancer | Transplant Surgery | Transplants | UK Health